Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Common Equity (2016 - 2025)

Historic Common Equity for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $236.0 million.

  • Anterix's Common Equity rose 6301.15% to $236.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $236.0 million, marking a year-over-year increase of 6301.15%. This contributed to the annual value of $156.6 million for FY2025, which is 275.16% down from last year.
  • As of Q4 2025, Anterix's Common Equity stood at $236.0 million, which was up 6301.15% from $240.3 million recorded in Q3 2025.
  • In the past 5 years, Anterix's Common Equity registered a high of $240.3 million during Q3 2025, and its lowest value of $139.1 million during Q3 2024.
  • Its 5-year average for Common Equity is $181.9 million, with a median of $177.9 million in 2023.
  • Per our database at Business Quant, Anterix's Common Equity tumbled by 2212.59% in 2022 and then soared by 7283.32% in 2025.
  • Over the past 5 years, Anterix's Common Equity (Quarter) stood at $195.6 million in 2021, then decreased by 18.71% to $159.0 million in 2022, then rose by 8.33% to $172.3 million in 2023, then decreased by 15.97% to $144.7 million in 2024, then skyrocketed by 63.01% to $236.0 million in 2025.
  • Its last three reported values are $236.0 million in Q4 2025, $240.3 million for Q3 2025, and $184.8 million during Q2 2025.